236 related articles for article (PubMed ID: 10215035)
1. Development of (p-O-sulfamoyl)-N-alkanoyl-phenylalkyl amines as non-steroidal estrone sulfatase inhibitors.
Kolli A; Chu GH; Rhodes ME; Inoue K; Selcer KW; Li PK
J Steroid Biochem Mol Biol; 1999 Jan; 68(1-2):31-40. PubMed ID: 10215035
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of estrone sulfatase and proliferation of human breast cancer cells by nonsteroidal (p-O-sulfamoyl)-N-alkanoyl tyramines.
Selcer KW; Hegde PV; Li PK
Cancer Res; 1997 Feb; 57(4):702-7. PubMed ID: 9044848
[TBL] [Abstract][Full Text] [Related]
3. Development of potent non-estrogenic estrone sulfatase inhibitors.
Li PK; Chu GH; Guo JP; Peters A; Selcer KW
Steroids; 1998; 63(7-8):425-32. PubMed ID: 9654650
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of placental estrone sulfatase activity and MCF-7 breast cancer cell proliferation by estrone-3-amino derivatives.
Selcer KW; Jagannathan S; Rhodes ME; Li PK
J Steroid Biochem Mol Biol; 1996 Sep; 59(1):83-91. PubMed ID: 9009241
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and sulfatase inhibitory activities of non-steroidal estrone sulfatase inhibitors.
Li PK; Milano S; Kluth L; Rhodes ME
J Steroid Biochem Mol Biol; 1996 Sep; 59(1):41-8. PubMed ID: 9009236
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological activity of the superestrogen (E)-17-oximino-3-O-sulfamoyl-1,3,5(10)-estratriene: x-ray crystal structure of (E)-17-oximino-3-hydroxy-1,3,5(10)-estratriene.
Hejaz HA; Purohit A; Mahon MF; Reed MJ; Potter BV
J Med Chem; 1999 Aug; 42(16):3188-92. PubMed ID: 10447965
[TBL] [Abstract][Full Text] [Related]
7. Steroidal and nonsteroidal sulfamates as potent inhibitors of steroid sulfatase.
Woo LW; Howarth NM; Purohit A; Hejaz HA; Reed MJ; Potter BV
J Med Chem; 1998 Mar; 41(7):1068-83. PubMed ID: 9544207
[TBL] [Abstract][Full Text] [Related]
8. Steroidal oxathiazine inhibitors of estrone sulfatase.
Peters RH; Chao WR; Sato B; Shigeno K; Zaveri NT; Tanabe M
Steroids; 2003 Jan; 68(1):97-110. PubMed ID: 12475726
[TBL] [Abstract][Full Text] [Related]
9. Estrogenicity, antiestrogenicity and estrone sulfatase inhibition of estrone-3-amine and estrone-3-thiol.
Selcer KW; Li PK
J Steroid Biochem Mol Biol; 1995 Mar; 52(3):281-6. PubMed ID: 7696150
[TBL] [Abstract][Full Text] [Related]
10. Review of estrone sulfatase and its inhibitors--an important new target against hormone dependent breast cancer.
Ahmed S; Owen CP; James K; Sampson L; Patel CK
Curr Med Chem; 2002 Jan; 9(2):263-73. PubMed ID: 11860358
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of steroid sulfatase by an active site-directed inhibitor, estrone-3-O-sulfamate.
Purohit A; Williams GJ; Howarth NM; Potter BV; Reed MJ
Biochemistry; 1995 Sep; 34(36):11508-14. PubMed ID: 7547880
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationship studies of the amide functionality in (p-O-sulfamoyl)-N-alkanoyl tyramines as estrone sulfatase inhibitors.
Chu GH; Milano S; Kluth L; Rhodes M; Boni R; Johnson DA; Li PK
Steroids; 1997 Jul; 62(7):530-5. PubMed ID: 9253792
[TBL] [Abstract][Full Text] [Related]
13. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.
Pasqualini JR; Chetrite GS
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):221-36. PubMed ID: 15860265
[TBL] [Abstract][Full Text] [Related]
14. Stilbene-based inhibitors of estrone sulfatase with a dual mode of action in human breast cancer cells.
Walter G; Liebl R; von Angerer E
Arch Pharm (Weinheim); 2004 Dec; 337(12):634-44. PubMed ID: 15597397
[TBL] [Abstract][Full Text] [Related]
15. Non-steroidal and steroidal sulfamates: new drugs for cancer therapy.
Purohit A; Woo LW; Barrow D; Hejaz HA; Nicholson RI; Potter BV; Reed MJ
Mol Cell Endocrinol; 2001 Jan; 171(1-2):129-35. PubMed ID: 11165021
[TBL] [Abstract][Full Text] [Related]
16. Strong inhibition of estrone-3-sulfatase activity by pregnenolone 16alpha-carbonitrile but not by several analogs lacking a 16alpha-nitrile group.
Zhu BT; Kosh JW; Fu J; Cai MX; Xu S; Conney AH
Steroids; 2000 Sep; 65(9):521-7. PubMed ID: 10978731
[TBL] [Abstract][Full Text] [Related]
17. Development of novel steroid sulfatase inhibitors; II. TZS-8478 potently inhibits the growth of breast tumors in postmenopausal breast cancer model rats.
Saito T; Kinoshita S; Fujii T; Bandoh K; Fuse S; Yamauchi Y; Koizumi N; Horiuchi T
J Steroid Biochem Mol Biol; 2004 Feb; 88(2):167-73. PubMed ID: 15084348
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of estrone sulfatase activity by estrone-3-methylthiophosphonate: a potential therapeutic agent in breast cancer.
Duncan L; Purohit A; Howarth NM; Potter BV; Reed MJ
Cancer Res; 1993 Jan; 53(2):298-303. PubMed ID: 8417823
[TBL] [Abstract][Full Text] [Related]
19. 2-phenylindole sulfamates: inhibitors of steroid sulfatase with antiproliferative activity in MCF-7 breast cancer cells.
Walter G; Liebl R; von Angerer E
J Steroid Biochem Mol Biol; 2004 Apr; 88(4-5):409-20. PubMed ID: 15145451
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of steryl sulfatase activity in LNCaP human prostate cancer cells.
Selcer KW; Kabler H; Sarap J; Xiao Z; Li PK
Steroids; 2002 Sep; 67(10):821-6. PubMed ID: 12231117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]